TherapeuticsMD (TXMD) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for TherapeuticsMD (TXMD) over the last 5 years, with Q3 2025 value amounting to $0.01.
- TherapeuticsMD's EPS (Weighted Average and Diluted) rose 12000.0% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 10357.14%. This contributed to the annual value of $11.36 for FY2024, which is 10459.89% up from last year.
- Per TherapeuticsMD's latest filing, its EPS (Weighted Average and Diluted) stood at $0.01 for Q3 2025, which was up 12000.0% from $0.05 recorded in Q2 2025.
- TherapeuticsMD's 5-year EPS (Weighted Average and Diluted) high stood at $63.02 for Q4 2023, and its period low was -$5.7 during Q1 2022.
- In the last 5 years, TherapeuticsMD's EPS (Weighted Average and Diluted) had a median value of -$0.08 in 2024 and averaged $3.61.
- Data for TherapeuticsMD's EPS (Weighted Average and Diluted) shows a peak YoY increase of 191802.68% (in 2023) and a maximum YoY decrease of 10187.06% (in 2023) over the last 5 years.
- Quarter analysis of 5 years shows TherapeuticsMD's EPS (Weighted Average and Diluted) stood at -$4.98 in 2021, then soared by 162.71% to $3.12 in 2022, then soared by 1918.03% to $63.02 in 2023, then crashed by 81.01% to $11.97 in 2024, then crashed by 99.92% to $0.01 in 2025.
- Its last three reported values are $0.01 in Q3 2025, $0.05 for Q2 2025, and -$0.06 during Q1 2025.